English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 天
Greenwich LifeSciences公布GLSI-100安全性数据显示积极结果
Greenwich LifeSciences首席执行官Snehal Patel对初步安全性数据以及使用注射部位反应直径评估免疫反应程度的潜力表示满意。公司预计将进一步分析免疫反应数据并与IIb期结果进行比较。分析师保持乐观展望,共识目标价为38美元,显示出相对当前水平的显著上涨潜力。投资者可通过 InvestingPro 获取更深入的GLSI财务健康状况和增长前景分析。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Agrees to limited ceasefire
On judicial impeachment call
'Get Together' singer dies
Halts care for trans veterans
Fire danger continues for OK
Ordered to pay $54K+
Bryan Bedford to lead FAA
Earthquake shakes Bay Area
Texas midwife arrested
JFK files to be released
US retail sales rebound
Worker stole $1.6 million
Suffered from food poisoning
Corruption trial begins
Free checked bag promotion
Visits White House
WH says US won't return
Honduras plane crash
Tapped as top bank cop
Lebanon-Syria ceasefire
Reinstating fired workers
ISR conducts strikes in Gaza
Peru declares emergency
Delta plane wing hits runway
Lunar lander goes silent
Removing privacy setting
Judge demands answers
Parents on missing daughter
Stuck astronauts depart ISS
Trump revokes protection
反馈